MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds, net of issuance
costs, from issuing...
$6,425K
(3.48%↑ Y/Y)
Net cash provided by
in financing...
$5,264K
(-32.70%↓ Y/Y)
Canceled cashflow
$1,161K
Net increase
(decrease) in cash and cash...
$368K
(252.70%↑ Y/Y)
Canceled cashflow
$4,896K
Payment made under the
warrant exchange...
$1,100K
Payment of preferred
stock dividend
$61K
Gain on
deconsolidation of subsidiary
$4,947K
Prepaid expenses and
other assets
-$4,087K
(8.61%↑ Y/Y)
Stock-based compensation
$2,334K
(294.26%↑ Y/Y)
Depreciation
$5K
(-16.67%↓ Y/Y)
Changes in lease
liability
$2K
(105.41%↑ Y/Y)
Net cash used in
operating activities
-$4,770K
(40.30%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$126K
(-72.60%↓ Y/Y)
Canceled cashflow
$11,375K
Accounts payable,
accrued and other...
-$10,506K
(-480.12%↓ Y/Y)
Net loss
-$2,998K
(73.26%↑ Y/Y)
Inventory
$1,384K
Accounts receivable, net
$1,257K
Back
Back
Cash Flow
source: myfinsight.com
Bio Green Med Solution, Inc. (BGMS)
Bio Green Med Solution, Inc. (BGMS)